Cao; Chuanhai

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cao; Chuanhai.The latest application filed is for "compositions and methods for treating alzheimers disease".

Company Profile

8.22.24

Cao; Chuanhai - Tampa FL
Cao; Chuanhai - Temple Terrace FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer's disease Grant 11,446,276 - Cao September 20, 2	2022-09-20
Compositions And Methods For Treating Alzheimers Disease App 20220280613 - Cao; Chuanhai	2022-09-08
Ultra-low Dose Thc As A Potential Therapeutic And Prophylactic Agent For Alzheimer's Disease App 20220265599 - Cao; Chuanhai	2022-08-25
Extreme Low Dose Thc As A Therapeutic And Prophylactic Agent For Alzheimer's Disease App 20220265598 - Cao; Chuanhai	2022-08-25
COMPOSITIONS AND METHODS RELATING TO NOVEL SULFONO-gamma-AA PEPTIDES App 20220220167 - Cao; Chuanhai ; et al.	2022-07-14
Compounds and methods for reducing or inhibiting aggregation of proteins in a subject Grant 11,254,704 - Cai , et al. February 22, 2	2022-02-22
Ultra-low dose THC as a potential therapeutic and prophylactic agent for Alzheimer's disease Grant 11,065,225 - Cao July 20, 2	2021-07-20
Novel Compounds For The Treatment Of Neurodegenerative Diseases App 20210070801 - Cai; Jianfeng ; et al.	2021-03-11
Compounds for the treatment of neurodegenerative diseases Grant 10,836,793 - Cai , et al. November 17, 2	2020-11-17
Dead Antigen Stimulated Immature Heterogenous Dendritic Cells As Therapeutics For Diseases App 20200338173 - Cao; Chuanhai ; et al.	2020-10-29
Novel Compounds For The Treatment Of Neurodegenerative Diseases App 20200216491 - Cai; Jianfeng ; et al.	2020-07-09
Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for treatment of Parkinson's disease Grant 10,653,759 - Cao , et al.	2020-05-19
Compounds for the treatment of neurodegenerative diseases Grant 10,538,553 - Cai , et al. Ja	2020-01-21
Novel Compounds For The Treatment Of Neurodegenerative Diseases App 20190211059 - Cai; Jianfeng ; et al.	2019-07-11
Methods, Antibodies, and Vaccines Utilizing Epitopes of Alpha Synuclein for Treatment of Parkinson's Disease App 20190125847 - CAO; CHUANHAI ; et al.	2019-05-02
Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for treatment of parkinsons disease Grant 10,155,030 - Cao , et al. Dec	2018-12-18
Prevention and treatment of brain diseases and disorders related to abnormal protein aggregation through electromagnetic field treatment Grant 10,149,982 - Arendash , et al. Dec	2018-12-11
Methods of synthesizing .gamma.-AApeptides, .gamma.-AApeptide building blocks, .gamma.-AApeptide libraries, and .gamma.-AApeptide inhibitors of A.beta..sub.40 aggregates Grant 10,022,420 - Cai , et al. July 17, 2	2018-07-17
Methods Of Synthesizing Gamma-aapeptides, Gamma-aapeptide Building Blocks, Gamma-aapeptide Libraries, And Gamma-aapeptide Inhibitors Of Alpha-beta40 Aggregates App 20170232055 - Cai; Jianfeng ; et al.	2017-08-17
Methods, Antibodies, and Vaccines Utilizing Epitopes of Alpha Synuclein for Treatment of Parkinsons Disease App 20170196948 - Cao; Chuanhai ; et al.	2017-07-13
Methods of synthesizing .gamma.-aapeptides, .gamma.-aapeptide building blocks, .gamma.-aapeptide libraries, and .gamma.-aapeptide inhibitors of A.beta..sub.40 aggregates Grant 9,645,155 - Cai , et al. May 9, 2	2017-05-09
METHODS OF SYNTHESIZING y-AAPEPTIDES, y-AAPEPTIDE BUILDING BLOCKS, y-AAPEPTIDE LIBRARIES, AND y-AAPEPTIDE INHIBITORS OF Ab40 AGGREGATES App 20160209422 - CAI; Jianfeng ; et al.	2016-07-21
Prevention And Treatment Of Brain Diseases And Disorders Related To Abnormal Protein Aggregation Through Electromagnetic Field Treatment App 20160106997 - Arendash; Gary W. ; et al.	2016-04-21
Prevention and treatment of alzheimer'S disease through electromagnetic field exposure Grant 9,238,149 - Arendash , et al. January 19, 2	2016-01-19
Immunotherapy For Treatment Of Amyloid-related Disorders Using Encapsulated Beta-amyloid Peptides App 20140170225 - CAO; CHUANHAI ; et al.	2014-06-19
Method of diagnosing or assessing risk for Parkinson's disease or Alzheimer's disease using TCR clonality Grant 8,383,347 - Cao , et al. February 26, 2	2013-02-26
Amyloid beta peptides and methods of use Grant 8,188,046 - Cao May 29, 2	2012-05-29
Prevention And Treatment Of Alzheimer's Disease Through Electromagnetic Field Exposure App 20120065456 - Arendash; Gary W. ; et al.	2012-03-15
Anti-HIV activity of the opioid antagonist naloxone Grant 8,067,430 - Ugen , et al. November 29, 2	2011-11-29
Amyloid Beta Peptides And Methods Of Use App 20100172879 - Cao; Chuanhai	2010-07-08
Immunotherapy for Treatment of Amyloid-Related Disorders Using Encapsulated Beta-Amyloid Peptides App 20100136063 - CAO; CHUANHAI ; et al.	2010-06-03
A Method for the Separation Anti-Amyloid Beta Antibody with Amyloid Beta Peptide App 20070015218 - Cao; Chuanhai ; et al.	2007-01-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.